SCIENTIFIC EVENTS

IABS 10th Annual Statistics Workshop 

November 12-14, 2024
Washington DC, USA 

Learn more

Avoiding Antimicrobial Resistance: Veterinary use of Phages for Prevention, Therapy and Control of Bacterial Infections

November 19-20, 2024
A virtual meeting

Learn More

4th Conference on Next Generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animal

NGS Training Workshop
December 3, 2024
4th NGS Conference
December 4 & 5, 2024
Frankfurt, Germany

Learn more

Advances in Analytical Technologies for
Biopharmaceutical Products

March 19-21, 2025
Rockville, MD, USA 

Learn more

Leveraging Analytical and Bioprocess Platforms for
Biological Product Development and Commercialization

May 14-15, 2025
Brussels, Belgium

Learn more

AFSA – IABS Conference about Animal testing replacement for vaccines: A One Health View: global outlook and future strategy

December 2-4, 2025
Bangkok, Thailand

Save the date

NEWS

ADVAC

Save the date

High Pathogenicity Avian Influenza (HPAI) in poultry, wild birds and wildlife mammals is a global challenge. The spread of the H5Nx 2.3.4.4b lineage of HPAI is now threatening to become truly global…

Learn more

President's Column September 2024

Dear IABS members and stakeholders, Our journal, Biologicals, reached an important milestone in 2023; it’s 50th Anniversary. If you have not read Volumn 85, February 2024, I suggest…

Read more

Save the date

2024 is a key year for globally considering NGS implementation with the recent publication of the revised ICHQ5A(R2) guideline and the upcoming draft chapter on NGS from the EDQM/European…

Learn more

IABS COLLABORATIONS

Inno4Vac – Innovations to accelerate vaccine development and manufacture

Inno4Vac is a public-private partnership that addresses scientific bottlenecks in vaccine development.

It proposes to develop predictive biological and mathematical models of vaccine performance and bio-manufacturing.

The IABS European Affiliate (IABS-EU) is part of consortia and has been selected to drive the regulatory part of the project.

ASFaVIP – African swine fever attenuated live
vaccines in pigs

TESTIMONIALS

Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more